Regio Zuid-Holland | Platform for parallelized biological tests

BI/OND aims at changing the lives of millions of patients by providing innovative hardware solutions for enabling personalized medicines. Nowadays, biologists must choose between two options when running pre-clinical models in the early phase of drug testing: in vivo studies conducted on animals or in vitro screening. However, in vitro model and animals have shown to be inadequate for testing new pharmaceuticals to treat the many diseases that afflict humans. Organ on a chip are one of the most promising tools to disrupt the pre-clinical drug development, reduce animals and enabling personalized medicine by combining the use of microchips with 3D tissue models. However, the use of organ on a chip technology still heavily relies on very labour and time intensive activity. As deeply focused on hardware solutions, Bi/ond is currently investigating the possibility to integrate automated and parallelized tests. In this project, Bi/ond will investigate on creating an interface for parallelized tests that the user will be able to control in an easy way, and develop a business plan around it.